首页> 美国卫生研究院文献>Molecular Medicine >Unmasking the anti-La/SSB response in sera from patients with Sjogrens syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants.
【2h】

Unmasking the anti-La/SSB response in sera from patients with Sjogrens syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants.

机译:通过特异性阻断针对La / SSB抗原决定簇的抗独特型抗体揭示干燥综合征患者血清中的抗La / SSB反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Autoantigen La/SSB is molecular target of humoral autoimmunity in patients with primary Sjogren's Syndrome (pSS) and systemic lupus erythematosus (SLE). In this study, we investigated the existence and possible influence of anti-idiotypic response to anti-La/SSB antibodies. MATERIALS AND METHODS: Synthetic peptide analogs (pep) of the major antigenic determinants of La/SSB (289-308 aa and 349-364 aa) were prepared. Based on "molecular recognition" theory, complementary peptides (cpep), derived by anti-parallel readings of the noncoding strand of La/SSB DNA encoding for its antigenic determinants, were constructed. Sera from 150 patients with anti-La/SSB antibodies, 30 patients without anti-La/SSB antibodies, and 42 normal individuals were tested against all four peptides. F(ab')(2) fragments from anti-peptide IgG were prepared and F(ab')(2) - IgG interactions were evaluated using a specific anti-idiotypic ELISA. RESULTS: All four peptides were recognized by anti-La positive sera (83% and 51% for pep and cpep 349-364 and 51% and 28% for pep and cpep289-308, respectively). Anti-cpep F(ab')(2 )bound to a common idiotype (Id) located within or spatially close to the antigen combining site of anti La/SSB (anti-pep) antibodies. Homologous and cross-inhibition experiments further confirmed this relation. The anti-idiotypic antibodies inhibited the anti-La/SSB antibody binding to recombinant La/SSB by 91%. To overcome the anti-idiotypic interference in anti-La/SSB detection, a specific assay was developed. Sera were heated for dissociation of Id-anti-Id complexes, anti-Id antibodies blocked with cpep, and anti-La/SSB reactivity was recovered. Application of this method to anti-Ro positive-anti-La/SSB "negative" sera showed that all anti-Ro/SSA positive autoimmune sera also possess anti-La/SSB antibodies. This reaction was not observed in 14 anti-Ro negative- anti-Sm/RNP positive sera from patients with SLE. CONCLUSIONS: Autoimmune sera from patients with pSS and SLE contain anti-idiotypic antibodies targeting a common anti-La/SSB idiotype. These antibodies can be detected using complementary peptides of La/SSB epitopes. The antiidiotypic antibodies mask the anti-La/SSB response. Hidden anti-La/SSB antibodies can be released and detected using complementary epitope analogs.
机译:背景:自身抗原La / SSB是原发性干燥综合征(pSS)和系统性红斑狼疮(SLE)患者体液自身免疫的分子靶标。在这项研究中,我们调查了抗La / SSB抗体的抗独特型反应的存在和可能的影响。材料与方法:制备了La / SSB主要抗原决定簇(289-308aa和349-364aa)的合成肽类似物(pep)。基于“分子识别”理论,构建了互补肽(cpep),该肽通过反平行读取编码其抗原决定簇的La / SSB DNA的非编码链而得到。测试了来自150例具有抗La / SSB抗体的患者,30例无抗La / SSB抗体的患者和42名正常个体的所有四种肽的血清。制备了来自抗肽IgG的F(ab')(2)片段,并使用特异性抗独特型ELISA评估了F(ab')(2)-IgG相互作用。结果:所有四个肽段均被抗La阳性血清识别(pep和cpep 349-364分别为83%和51%,pep和cpep289-308分别为51%和28%)。抗cpep F(ab')(2)与位于或在空间上接近抗La / SSB(抗Pep)抗体的抗原结合位点的共同独特型(Id)结合。同源和交叉抑制实验进一步证实了这种关系。抗独特型抗体将抗La / SSB抗体与重组La / SSB的结合抑制了91%。为了克服抗La / SSB检测中的抗独特型干扰,开发了一种特异性检测方法。加热血清以解离Id-抗-Id复合物,用cpep封闭抗-Id抗体,并回收抗La / SSB反应性。该方法在抗Ro /抗La / SSB“阴性”血清中的应用表明,所有抗Ro / SSA阳性的自身免疫血清也都具有抗La / SSB抗体。在SLE患者的14份抗Ro阴性抗Sm / RNP阳性血清中未观察到此反应。结论:来自pSS和SLE患者的自身免疫血清含有针对常见抗La / SSB独特型的抗独特型抗体。可以使用La / SSB表位的互补肽检测这些抗体。抗独特型抗体掩盖了抗La / SSB反应。可以使用互补表位类似物释放和检测隐藏的抗La / SSB抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号